Please Wait
Applying Filters...
menu
    • menu
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Ceflax

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aurobindo Pharma’s Generics Cephalexin Receives Approval in US
    Aurobindo Pharma’s Generics Cephalexin Receives Approval in US

    09 Jun 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213568

    FDA
    09 Jun 2026
    Share Share
    Invivyd Launches SPEAR Study on Long COVID Treatment
    Invivyd Launches SPEAR Study on Long COVID Treatment

    02 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/02/3109060/0/en/Invivyd-and-Leading-Researchers-Form-SPEAR-Spike-Protein-Elimination-and-Recovery-Study-Group-to-Assess-the-Effects-of-Monoclonal-Antibody-Therapy-for-Long-COVID-and-COVID-19-Post-.html

    GLOBENEWSWIRE
    02 Jul 2025
    Share Share
    SLAs Agree on Drug Approval Norms Compliance
    SLAs Agree on Drug Approval Norms Compliance

    02 Jul 2025

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=178853&sid=1

    PHARMABIZ
    02 Jul 2025
    Share Share
    Covid-19 jabs don't raise risk of sudden death: ICMR-NIE Director
    Covid-19 jabs don't raise risk of sudden death: ICMR-NIE Director

    02 Jul 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/covid-19-jabs-dont-raise-risk-of-sudden-death-icmr-nie-director/articleshow/122211629.cms

    ECONOMICTIMES
    02 Jul 2025
    Share Share
    Healx, SCI Ventures Unite to Find Paralysis Cures with AI
    Healx, SCI Ventures Unite to Find Paralysis Cures with AI

    01 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250701300647/en/Healx-and-SCI-Ventures-Join-Forces-to-Uncover-Cures-for-Paralysis-with-AI-Driven-Drug-Discovery

    BUSINESSWIRE
    01 Jul 2025
    Share Share
    UI Pharmaceuticals Partners with MimiVax for Glioblastoma Vaccine
    UI Pharmaceuticals Partners with MimiVax for Glioblastoma Vaccine

    30 Jun 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/ui-pharmaceuticals-partners-with-mimivax-for-glioblastoma-vaccine/

    CONTRACTPHARMA
    30 Jun 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.